 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Liver Complications in HIV-Infected Patients
- Updates to Prezista (Darunavir) Tablets Labeling (March 11, 2008)
From U.S. Food and Drug Administration - Non-Alcoholic Fatty Liver Disease Is Common in HAART-Experienced Patients; Several HIV- and Antiretroviral-Related Factors May Play Role (February 6, 2008)
From The Body PRO - Immune Reconstitution May Trigger Hepatic Flares in HIV/Hepatitis B Coinfected Patients Starting HAART (February 5, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Rapid Liver Fibrosis Occurring More Frequently Among HIV-Infected Men Newly Coinfected With Hepatitis C (February 4, 2008)
An interview with Daniel Fierer, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Tipranavir/Ritonavir-Associated Hepatotoxicity Common, But Resolves Over Time (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - Antiretroviral Exposure Not Associated With Liver-Related Deaths in D:A:D Cohort (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections - More Questions Than Answers Regarding High Hepatic Event Rates Among Thai Patients in 2NN Study (December 17, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Liver Disease Is Now Leading Cause of Death Among HIV-Positive British Hemophiliacs (September 22, 2005)
From aidsmap.com - Hepatitis Testing Important for HIVers Before Taking Kaletra (October 13, 2004)
From aidsmap.com - Hepatitis/HIV Coinfection Linked to Liver Complications in Kaletra Patients (September 2004)
Abstract of a study that recommends testing HIV-infected patients for HBV and HCV and measuring their baseline ALT values before lopinavir/ritonavir therapy is begun.
In HIV Medicine - Response to Lopinavir/Ritonavir in HIV-Infected Patients Coinfected With Hepatitis C and/or Hepatitis B (July 12, 2004)
In The XV International AIDS Conference, from The Body PRO - Nevirapine Hepatotoxicity Risks Clarified in New Letter to Healthcare Professionals (PDF) (February 2004)
From Boehringer Ingelheim - Liver Damage a Concern for HAART Patients With Hepatitis C, Low CD4 (May 1, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Low Incidence of Grade III/IV Hepatotoxicity in First HAART: Observations From 1,100 Patients Followed for 1 Year (July 9, 2002)
In The XIV International AIDS Conference, from The Body PRO - Antiretrovirals and Liver Toxicity: How Big a Concern? (Summer 2002)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America - Severe Liver Damage With TB Drugs (May 29, 2001)
From Canadian AIDS Treatment Information Exchange
  |
  |